Tirzepatide online access for Cambridge, Massachusetts
Company statements checked between September 13, 2026 and September 23, 2026: 3 covered companies — GoodRx Care, Mochi Health and OrderlyMeds — advertise online access to Tirzepatide for patients in Massachusetts, including Cambridge. Confirm eligibility and total charges with the provider.
Browse online Tirzepatide programs advertised for patients in Cambridge, Massachusetts, with state-level access evidence.
Inside Telehealth Editorial · Updated
At a glance
| Company | On this page | Lowest listed monthly figure | Checked | Official site |
|---|---|---|---|---|
| GoodRx Care | Zepbound KwikPen | $338/mo partial monthly subtotal, Zepbound KwikPen | Official site ↗ | |
| Mochi Health | Compounded tirzepatide | $169/mo partial monthly subtotal, Compounded tirzepatide | Official site ↗ | |
| OrderlyMeds | Zepbound | $1,498/mo advertised monthly bundle, Zepbound | Official site ↗ |
Health context in Cambridge
Tirzepatide programs are marketed for weight management and, for some products, type 2 diabetes. These Cambridge figures give local context only. Among the 5 Massachusetts cities in this research set, Cambridge has the lowest estimate for obesity among adults (24.1%), the lowest estimate for diagnosed diabetes among adults (7.9%), the lowest estimate for high blood pressure among adults (26.2%), the lowest estimate for lack of health insurance among adults aged 18–64 (3.5%) and the tied for highest estimate for routine checkup in the past year among adults (80%).
| Measure | Cambridge | 95% range | Among the 5 Massachusetts cities in this research set | Year |
|---|---|---|---|---|
| Obesity among adults | 24.1% | 21–27.4% | lowest | 2023 |
| Diagnosed diabetes among adults | 7.9% | 7.1–8.9% | lowest | 2023 |
| High blood pressure among adults | 26.2% | 24.1–28.4% | lowest | 2023 |
| Lack of health insurance among adults aged 18–64 | 3.5% | 3–4% | lowest | 2023 |
| Routine checkup in the past year among adults | 80% | 77.6–82.1% | tied for highest | 2023 |
Source: CDC PLACES, 2025 release — model-based estimates from the Behavioral Risk Factor Surveillance System for Census place geography (total population 118,403); each measure is an estimate for adults. These describe the city's adults as a group; they do not indicate whether any person is eligible for, or should use, a treatment listed here.
This tirzepatide page is the Cambridge entry point to the Massachusetts statewide online listing, not evidence of an office, pharmacy or clinician in Cambridge. Each company below appears because its named products have their own Massachusetts evidence; the heading does not extend coverage to every medicine in the category, and branded and compounded products are listed separately.
Use the Massachusetts guide to compare the listed programs, their separate prices and their billing and cancellation terms before choosing which offer to ask a company about.
These are online services advertised for patients in Massachusetts, listed alphabetically. They are not verified offices, pharmacies or clinicians located in Cambridge, and a listing is not a prescription, appointment or coverage guarantee. Read the Massachusetts Tirzepatide guide for product details, charges and limitations.
Selected providers
GoodRx Care
GoodRx Care Direct's separately priced branded tirzepatide pen, billed apart from its monthly membership fee.
Zepbound KwikPen (pen): introductory KwikPen strength (page labels it 10 mg) — $338/mo
- Zepbound KwikPen — pen: state evidence checked · Availability source · Full evidence notes
Mochi Health
Compounded tirzepatide orders through Mochi's paid membership route, if prescribed.
Compounded tirzepatide (injection): 2.2 mg/week — $169/mo · 4.4 mg/week — $198/mo · 6.6 mg/week — $223/mo · 8.8 mg/week — $253/mo · 11.24 mg/week — $263/mo · 13.2 mg/week — $273/mo · 16.6 mg/week — $278/mo
- Compounded tirzepatide — injection: state evidence checked · Availability source · Full evidence notes
OrderlyMeds
OrderlyMeds branded Zepbound injection plan.
Zepbound (pen): 2.5–15 mg (advertised range) — $1,498/mo
- Zepbound — pen: state evidence checked · Availability source · Full evidence notes
More listings
Other medications for Cambridge: GLP-1 medication access · Semaglutide
Tirzepatide in other Massachusetts cities: Boston · Lowell · Springfield · Worcester
Before requesting a prescription
Confirm the named product is offered where you will be during the visit, check eligibility, total charges and any supply commitment, and ask what happens if you need in-person care. This listing does not assess which treatment is right for you.